Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 56 | ECE2018 | Next issue

20th European Congress of Endocrinology

Barcelona, Spain
19 May 2018 - 22 May 2018

Card image cap
ECE 2018, 19 - 22 May 2018; Barcelona, Spain

Oral Communications

Clinical practice in endocrine tumours: combining conventional and molecular features

ea0056oc11.1 | Clinical practice in endocrine tumours: combining conventional and molecular features | ECE2018

Targeted molecular analysis in adrenocortical carcinomas: a way towards improved personalized prognostication

Lippert Juliane , Appenzeller Silke , Liang Raimunde , Sbiera Silviu , Kircher Stefan , Altieri Barbara , Nanda Indrajit , Weigand Isabel , Gehrig Andrea , Steinhauer Sonja , Mueller Clemens , Kroiss Matthias , Rost Simone , Rosenwald Andreas , Fassnacht Martin , Ronchi Cristina

Adrenocortical carcinoma (ACC) has heterogeneous prognosis and no effective targeted therapies. Pan-genomic studies identified complex molecular patterns related to outcome. Our study aimed at identification of an ‘easy-to-apply’ molecular signature for better personalized prognostic stratification. A total of 107 ACC patients were enrolled. Clinical/histopathological parameters of prognostic relevance were evaluated. Targeted molecular analysis was performed on DNA ...

ea0056oc11.2 | Clinical practice in endocrine tumours: combining conventional and molecular features | ECE2018

Molecular classifiers refine the prognostic stratification of adrenocortical carcinoma

Jouinot Anne , Assie Guillaume , Fassnacht Martin , Libe Rossella , Garinet Simon , Jacob Louis , Faillot Simon , Hamzaoui Nadim , Neou Mario , Sakat Julien , Perlemoine Karine , Sibony Mathilde , Tissier Frederique , Dousset Bertrand , Sbiera Silviu , Ronchi Cristina , Kroiss Matthias , Korpershoek Esther , De Krijger Ronald , Waldmann Jens , Quinkler Marcus , Tabarin Antoine , Chabre Olivier , Coste Joel , Luconi Michaela , Mannelli Massimo , Groussin Lionel , Bertagna Xavier , Baudin Eric , Amar Laurence , Beuschlein Felix , Bertherat Jerome

Background: Adrenocortical cancer (ACC) is an aggressive tumour with heterogeneous prognosis. Pan-genomic studies identified molecular subgroups of ACC, remarkably associated with outcome. For routine prospective use, targeted molecular measures are needed, combined into reasonably easy and cheap techniques. The aim was to develop and validate different combinations of targeted molecular markers reflecting the molecular subgroup, and compare their prognostic value to standard ...

ea0056oc11.3 | Clinical practice in endocrine tumours: combining conventional and molecular features | ECE2018

Clinical and histopathological differences between MEN1 carriers and MEN1 phenocopy patients

Isailovic Tatjana , Macut Djuro , Milicevic Ivana , Petakov Milan , Ognjanovic Sanja , Kovacevic Valentina Elezovic , Popovic Bojana , Antic Ivana Bozic , Bogavac Tamara , Ilic Dusan , Dumanovic Mirjana Sumarac , Stojkovic Mirjana , Damjanovic Svetozar

Introduction: Multiple endocrine neoplasia type 1 (MEN1) is a rare multitumour syndrome, characterized by the occurrence of parathyroid (PHPT), pituitary adenoma (PA) and pancreatic neuroendocrine tumors (pNETs). The gene responsible is MEN1 gene, however 10 to 20% of patients are not carriers of MEN1 mutation. Recently, a study has shown that these patients have less aggressive course of the disease, and more favorable life expectancy than their mutation-pos...

ea0056oc11.4 | Clinical practice in endocrine tumours: combining conventional and molecular features | ECE2018

Update in the genetic landscape of Cushing’s Disease: TP53 and a new deubiquitinase in spotlight

Sbiera Silviu , Popov Nikita , Weigand Isabel , Flitsch Jorg , Perez-Rivas Luis Gustavo , Taranets Lyudmyla , Graf Elisabeth , Monoranu Camelia-Maria , Saeger Wolfgang , Hagel Christian , Theodoropoulou Marily , Stalla Gunther , Herterich Sabine , Ronchi Cristina L. , Deutschbein Timo , Reincke Martin , Strom Tim M. , Fassnacht Martin

Introduction: Cushing’s disease (CD) is caused by pituitary tumors hypersecreting adrenocorticotropin (ACTH). Until now somatic mutations in the 14-3-3 binding domain of Ubiquitin Specific Peptidase 8 gene (USP8) were the only recurring, driver mutations and were described in about 40% of the 446 CD samples that have been analysed wordwide. We wanted to assess if other driver mutations might be the pathogenetic cause of CD in those tumors without USP8 mu...

ea0056oc11.5 | Clinical practice in endocrine tumours: combining conventional and molecular features | ECE2018

Natural history of Rathke’s Cleft Cysts: a multicenter experience

Sala Elisa , Moore Justin M , Amorin Alvaro , Carosi Giulia , Harsh Griffith R , Arosio Maura , Mantovani Giovanna , Katznelson Laurence

Objective: Rathke’s Cleft Cyst (RCC) is a common incidental type of sellar lesion, and, depending on size, may cause local mass effects with visual impairment, hypopituitarism, and headaches. In this study, we sought to define the natural history of RCC.Methods: We performed a retrospective study of patients diagnosed with RCC between 2000 and 2016 at Stanford University Hospital, US, and Ospedale Maggiore Policlinico di Milano, Italy. Aim of the st...